UC San Diego scientists have found the most common form of liver cancer could be targeted and treated more effectively using a stem cell-derived therapy, according to a report published Tuesday. The report, published in the scientific journal Cell Stem Cell, focuses on hepatocellular carcinoma, a cancer with a high mortality rate. While not yet studied in patients, the treatment — which involves the lab engineering of “natural killer” white blood cells to battle HCC — could be mass-produced and ready for deployment rapidly, the researchers said. Unlike a treatment called chimeric antigen receptor-expressing T-cell therapy, which requires patient personalization, the NK-cell the
Hence then, the article about ucsd team tests stem cell derived therapy on liver cancer results promising was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( UCSD Team Tests Stem Cell-Derived Therapy On Liver Cancer; Results Promising )